Ada J Kwong

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Tyrosine Kinase

Radiation Induced

Top Venues

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Dalton R Kim, Meghan J Orr, Xiaozhou Yu, Hasan H Munshi, Austin Wang, Claire Trudeau, Ada J Kwong, Shi-Yuan Cheng, Karl A Scheidt
Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma. ACS medicinal chemistry letters 15 (2) (2024)
Dalton R Kim, Meghan J Orr, Xiaozhou Yu, Hasan H Munshi, Austin Wang, Claire Trudeau, Ada J Kwong, Shi-Yuan Cheng, Karl A Scheidt
Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma. ACS medicinal chemistry letters 15 (2) (2024)
Dalton R Kim, Meghan J Orr, Xiaozhou Yu, Hasan H Munshi, Austin Wang, Claire Trudeau, Ada J Kwong, Shi-Yuan Cheng, Karl A Scheidt
Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma. ACS medicinal chemistry letters 15 (2) (2024)
Dalton R Kim, Meghan J Orr, Ada J Kwong, Kristine K Deibler, Hasan H Munshi, Cory Seth Bridges, Taylor Jie Chen, Xiaoyu Zhang, H Daniel Lacorazza, Karl A Scheidt
Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors. ACS medicinal chemistry letters 14 (5) (2023)
Dalton R Kim, Meghan J Orr, Ada J Kwong, Kristine K Deibler, Hasan H Munshi, Cory Seth Bridges, Taylor Jie Chen, Xiaoyu Zhang, H Daniel Lacorazza, Karl A Scheidt
Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors. ACS medicinal chemistry letters 14 (5) (2023)
Ada J Kwong, Thao N D Pham, Hannah E Oelschlager, Hidayatullah G Munshi, Karl A Scheidt
Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma. ACS medicinal chemistry letters 12 (10) (2021)